Last reviewed · How we verify
NCT07477197: HIBR-ACHD
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
trial in Adult Congenital Heart Disease in 5,000 participants. Currently enrolling.
1 January 2050
Quick facts
| Lead sponsor | Children's Hospital Medical Center, Cincinnati |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 July 2021 |
| Primary completion | 1 January 2050 |
| Estimated completion | 1 January 2050 |
| Sites | 1 location across United States |
Conditions studied
- Adult Congenital Heart Disease — all drugs for Adult Congenital Heart Disease →
- Pulmonary Hypertension — all drugs for Pulmonary Hypertension →
- Connective Tissue Disease — all drugs for Connective Tissue Disease →
- Other Cardiovascular Conditions — all drugs for Other Cardiovascular Conditions →
Sponsor
Children's Hospital Medical Center, Cincinnati
Who can join
16 and older, any sex, with Adult Congenital Heart Disease or Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of patient experience and functional status; associations between clinical characteristics and various biomarkers; and predictors of clinical outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07477197
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adult Congenital Heart Disease
Currently open trials in the same condition.
- NCT06775639 — Should we Avoid Performing Invasive Coronary Angiography Before Cardiac Surgery in ACHD Patients? · recruiting
- NCT06260059 — Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease · Phase 4 · recruiting
- NCT06769529 — Observational Cohort Study of Adult Patients With Congenital Heart Disease · recruiting
- NCT06784440 — Search for Noninvasive Markers of "Graft Injury" in Pediatric and Adult Patients With Congenital Heart Disease Undergoin · NA · recruiting
- NCT06932081 — Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry · recruiting
Other Children's Hospital Medical Center, Cincinnati trials
Trials by the same sponsor.
- NCT07430332 — GLP-1 RA for Stage 1 Type 1 Diabetes · Phase 2 · not yet recruiting
- NCT07077213 — 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients · recruiting
- NCT07265141 — An Automated Virtual Reality Intervention to Enhance Firearm Safety Counseling in Pediatrics · NA · not yet recruiting
- NCT07217444 — Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation · NA · recruiting
- NCT07195123 — Evaluation of the SMART IBD App in Pediatric IBD · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07477197 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07477197.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing